Richard Pallin
Vice President of In Vitro Diagnostic Sales
Richard is an experienced and successful commercial leader with a demonstrated history of working in the global diagnostics and biotechnology industries. Before joining Virax, he was the Vice President of Global Commercial Operations of Omixon, a global transplantation diagnostic company dedicated to transitioning the human leukocyte antigen community to Next Generation Sequencing (NGS) technologies. Prior to that, he was the Director of Commercial Operations for Singulex, the developer and leading provider of single molecule counting technology for clinical diagnostics and scientific discovery. Richard also held senior commercial roles at Genmark Diagnostics UK, Vela Diagnostics GmbH, Luminex B.V., Affymetrix and Roche Diagnostics. He is a strong business development professional with a BSc focused in molecular biology, infectious diseases, and oncology, from The University of Sunderland.